A UNIFORM PROBABILISTIC APPROACH TO MANAGE UNCERTAINTIES REGARDING VACCINE EFFECTIVENESS AGAINST SEROTYPE 3, 19A, NTHI AND HERD EFFECT IN THE BASE CASE OF A COST-EFFECTIVENESS ANALYSIS COMPARING NON-TYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN D (PHID-CV) WITH 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINES (PCV13) IN INFANTS